Skip to content
  • Facebook
  • Twitter
  • linkedin
Open Access Publisher of Medical and Social Science Journals
Openventio Publishers
  • Home
  • About us
    • Vision/Mission
    • Open Access
    • Editorial Assessment and Peer Review Process
  • Journals
  • Editorial Guidelines
    • For Authors
    • For Editors
    • For Reviewers
    • For Readers
    • For Librarians
  • Submit Manuscript
  • Contact Us
  • More
    • Advertisement
    • Reprints
    • Privacy Policy
    • FAQs

Volume 1, Issue 4

  • 2015, July

    review

    Therapeutic and Chemopreventive Effects of Ursodeoxycholic Acid (UDCA): Potential Role in Patients with Barrett’s EsophagusOpen Access

    Xiaofang Huo*
    DOI: http://dx.doi.org/10.17140/GOJ-1-115
    PDF379.78 KB 379.78 KB
    Full-Text (HTML)

  • 2015, August

    original research

    Tenofovir Disoproxil Fumarate Treatment for Pediatric Patients with Perinatally Acquired Chronic Hepatitis BOpen Access

    Ricardo A. Arbizu*, Susan S. Baker, Rafal Kozielski and Robert D. Baker
    DOI: http://dx.doi.org/10.17140/GOJ-1-116
    PDF539.11 KB 539.11 KB
    Full-Text (HTML)

  • 2015, September

    original research

    Capsule Endoscopy: Indications, Findings and Complications among Patients with Suspected Small Bowel LesionsOpen Access

    Abdelmounem Eltayeib Abdo* and Dina Ali Mohammed
    DOI: http://dx.doi.org/10.17140/GOJ-1-117
    PDF461.09 KB 461.09 KB
    Full-Text (HTML)

  • 2015, September

    editorial

    A Double-Edged Sword and Swinging Pendulum: The Evolving Role of Percutaneous Endoscopic Gastrostomy Tubes in Patients with Advanced DementiaOpen Access

    Tawfik Khoury, Ayman Abu Rmeileh, Jonah Cohen and Meir Mizrahi*
    DOI: http://dx.doi.org/10.17140/GOJ-1-e002
    PDF340.80 KB 340.80 KB
    Full-Text (HTML)

  • 2015, October

    original research

    Effect of Chronic Proton Pump Inhibitor Use on Serum Magnesium Levels in Pediatric PatientsOpen Access

    Amy Stanford and Riad Rahhal*
    DOI: http://dx.doi.org/10.17140/GOJ-1-118
    PDF467.95 KB 467.95 KB
    Full-Text (HTML)

×

Article in press

NOTE: The DOIs of the In-Press Articles will only function after the final publication of the articles and once they are uploaded to the Current Issues.
×

Current Issue

  • 2020, February

    case report

    Superior Mesenteric Artery and Nutcracker Syndromes in a Healthy 14-Year-Old Girl Requiring Surgical Intervention after Failed Conservative ManagementOpen Access

    David Wood, Andrew Fagbemi, Loveday Jago, Dalia Belsha, Nick Lansdale and Ahmed Kadir
    DOI: http://dx.doi.org/10.17140/GOJ-5-132
    PDF360.10 KB 360.10 KB
    Full-Text (HTML)
    Full-Text (HTML)
    Abstract [+]

    This case report presents the diagnosis of superior mesenteric artery and nutcracker syndromes in a previously fit and well 14-year-old girl. Although these two entities usually occur in isolation, despite their related aetiology, our patient was a rare example of their occurrence together. In this case the duodenal compression of superior mesenteric artery syndrome caused intractable vomiting leading to weight loss, and her nutcracker syndrome caused severe left-sided abdominal pain and microscopic haematuria without renal compromise. Management of the superior mesenteric artery syndrome can be conservative by increasing the weight of the child which leads to improvement of retroperitoneal fat and hence the angle of the artery. The weight can be improved either by enteral feeds or parenteral nutrition. This conservative management initially helped but not in the long-term as the child started losing weight again. The next step in management is surgery (duodenojejunostomy – if the conservative management fails), which the child went through, remarkably improving their symptoms.


  • 2021, June

    review

    Decision-Making in Diagnosis and Management of Extraintestinal Manifestations of Inflammatory Bowel DiseaseOpen Access

    Nicholas V. Costrini*
    DOI: http://dx.doi.org/10.17140/GOJ-5-133
    PDF450.17 KB 450.17 KB
    Full-Text (HTML)
    Full-Text (HTML)
    Abstract [+]

    In the absence of certainty regarding the causes of both inflammatory bowel disease (IBD) and its extraintestinal manifestations (EIMs), there is necessarily ambiguity in both academic and clinical arenas concerning the diagnosis, classifications, and treatments of EIMs. While the “true” EIMs are considered extensions of the IBD gut pathogenesis with an immunologically mediated inflammatory consequence, other EIMs are considered to be complications of IBD itself or its treatment. A third group of IBD EIMs includes those disorders which seem to occur more often in IBD but for which an etiologic or pathophysiologic connection to IBD is highly theoretical. Patients with IBD and EIMs tend to have more severe, long-duration disease, and a reduced quality of life. EIMs presentation may or may not parallel IBD gut inflammatory activity. The clinical decision-making processes necessary for successfully managing simultaneously the gut component of IBD and its EIMs are presented. Based upon clinical experience and review of leading publications, the consensus of best practices, differential diagnoses for EIMs, and
    current management programs are presented with enumeration of specific decisions and considerations required for successful management of EIMs. EIMs of inflammatory bowel disease reflect the immunopathologic common ground and hence the systemic nature of the IBD. A defined decision-making process is offered which includes consultations and attention to the differential diagnosis to avoid not uncommon mistakes in diagnosis. Management of all EIMs requires assessment of both the clinical and pathologic status
    of the gut component of IBD combined with judicious selection of general and /or immunosuppression therapy for the EIMs.
    Keywords
    Ulcerative colitis; Crohn’s disease; Erythema nodosum; Pyoderma gangrenosum; Primary sclerosing cholangitis; Spondyloarthritis; Uveitis; Paradoxical dermatitis.


×

Previous Issue

  • 2019, May

    letter to the editor

    Endoscopic Treatment of Refractory Variceal BleedOpen Access

    Shreyas Saligram*, Marina Roytman, Helen Wong and ThimmaiahTheethira
    DOI: http://dx.doi.org/10.17140/GOJ-4-128
    PDF307.70 KB 307.70 KB
    Full-Text (HTML)

  • 2019, September

    letter to the editor

    Call Me Anything but Thoughtless or Misguided in IBD ManagementOpen Access

    Nicholas V. Costrini*
    DOI: http://dx.doi.org/10.17140/GOJ-4-129
    PDF242.88 KB 242.88 KB
    Full-Text (HTML)

  • 2019, November

    opinion

    What IBD Physicians Can Learn from Major League Baseball ManagersOpen Access

    Nicholas V. Costrini*
    DOI: http://dx.doi.org/10.17140/GOJ-4-130
    PDF214.56 KB 214.56 KB
    Full-Text (HTML)

  • 2019, December

    case report

    The Importance of Enzyme Substitution Therapy in Early Pancreas Exocrines of InsufficiencyOpen Access

    Biljana Petrovic*
    DOI: http://dx.doi.org/10.17140/GOJ-4-131
    PDF257.68 KB 257.68 KB
    Full-Text (HTML)
    Abstract [+]

    Introduction

    Functional disorders of the digestive tract are a common occurrence in the doctor’s office. In addition to functional dyspepsia, 35% of dyspepsia are unresolved dyspepsia, which are a symptom of the early stage of pancreatic exocrine insufficiency.

    Aim

    Based on clinical experience, we can suspect and detect chronic pancreatic insufficiency at an early stage, which is the aim of this paper.

    Method

    To demonstrate the efficacy of enzyme replacement therapy in the early stage of pancreatic exocrine insufficiency using the case report of the patient.

    Results

    Results confirms significance and effectiveness of creon as an enzyme replacement therapy in the treatment of malabsorption and maldigestion.

    Conclusion

    Creon (pancreatin) showed great effect in the treatment of dyspepsia and anorexia nervosa, body mass index (BMI) for 30 days increased from 15.9 to 17.4, which leads us to the conclusion that unrecognized chronic pancreatic insufficiency can be expected in long-term dyspepsia.

    Keywords

    Chronic pancreatic insufficiency; Enzyme; Body mass index (BMI); Digestive tract.


    • Home
    • Authors Instructions
    • Submit Manuscript
    • Contact Us
    • Editorial Panel
    • Article in press
    • Current issue
    • Previous issue
    • Archive
    • Archive

    Connect with us



    Associate Editors

    Tatiana Goretsky (Zagranichnaya), PhD


    Assistant Professor
    Division of Digestive Diseases and Nutrition
    Department of Internal Medicine
    University of Kentucky
    Lexington, KY 40506, USA

    Jacintha O. Sullivan, PhD


    Associate Professor
    Department of Surgery
    Institute of Molecular Medicine
    Trinity Centre for Health Sciences
    St James Hospital
    Dublin 8, Ireland

    Shreyas Saligram, MD, MRCP


    Department of of Interventional
    Gastroenterology
    Moffitt Cancer Center
    Department of Gastroenterology
    Kansas University Medical Center
    235 Ward Parkway, Apt 307
    Kansas City, MO-64112, USA

    Our editorial team


    Advertisement

    About Openventio

    Openventio Publishers is licensed under a Creative Commons Attribution 4.0 International License.
    based on the work at www.openventio.org

    Quick Links
    • Open Access
    • Submit Manuscript
    • Authors Instructions
    • Journals
    • Editorial Guidelines
    • Contact Us
    • Reprints
    • FAQs
    • Advertisement
    Find Us

    Suite#B013, Nexus Business Center
    Block-B, Level 2, Road no. 3
    Film Nagar, Hyderabad
    Telangana State, India

    Openventio Publishers
    • Facebook
    • Twitter
    • linkedin
    © 2014 - 2022 Openventio Publishers. All Rights Reserved.
    • Open Access
    • Submit Manuscript
    • Authors Instructions
    • Journals
    • Editorial Guidelines
    • Contact Us
    • Reprints
    • FAQs
    • Advertisement